Cargando…
MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty
Aim. This study was designed to evaluate the relationship between microRNAs (miRNAs), miR-126-3p and miR-223-3p, as new biomarkers of platelet activation, and predicting recurrent thrombotic events after acute myocardial infarction (AMI). Methods and Results. The analysis included 598 patients rando...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230013/ https://www.ncbi.nlm.nih.gov/pubmed/34199723 http://dx.doi.org/10.3390/jpm11060508 |
_version_ | 1783713107249463296 |
---|---|
author | Hromadka, Milan Motovska, Zuzana Hlinomaz, Ota Kala, Petr Tousek, Frantisek Jarkovsky, Jiri Beranova, Marketa Jansky, Pavel Svoboda, Michal Krepelkova, Iveta Rokyta, Richard Widimsky, Petr Karpisek, Michal |
author_facet | Hromadka, Milan Motovska, Zuzana Hlinomaz, Ota Kala, Petr Tousek, Frantisek Jarkovsky, Jiri Beranova, Marketa Jansky, Pavel Svoboda, Michal Krepelkova, Iveta Rokyta, Richard Widimsky, Petr Karpisek, Michal |
author_sort | Hromadka, Milan |
collection | PubMed |
description | Aim. This study was designed to evaluate the relationship between microRNAs (miRNAs), miR-126-3p and miR-223-3p, as new biomarkers of platelet activation, and predicting recurrent thrombotic events after acute myocardial infarction (AMI). Methods and Results. The analysis included 598 patients randomized in the PRAGUE-18 study (ticagrelor vs. prasugrel in AMI). The measurements of miRNAs were performed by using a novel miRNA immunoassay method. The association of miRNAs with the occurrence of the ischemic endpoint (EP) (cardiovascular death, nonfatal MI, or stroke) and bleeding were analyzed. The miR-223-3p level was significantly related to an increased risk of occurrence of the ischemic EP within 30 days (odds ratio (OR) = 15.74, 95% confidence interval (CI): 2.07–119.93, p = 0.008) and one year (OR = 3.18, 95% CI: 1.40–7.19, p = 0.006), respectively. The miR-126-3p to miR-223-3p ratio was related to a decreased risk of occurrence of EP within 30 days (OR = 0.14, 95% CI: 0.03–0.61, p = 0.009) and one year (OR = 0.37, 95% CI: 0.17–0.82, p = 0.014), respectively. MiRNAs were identified as independent predictors of EP even after adjustment for confounding clinical predictors. Adding miR-223-3p and miR-126-3p to miR-223-3p ratios as predictors into the model calculating the ischemic risk significantly increased the predictive accuracy for combined ischemic EP within one year more than using only clinical ischemic risk parameters. No associations between miRNAs and bleeding complications were identified. Conclusion. The miR-223-3p and the miR-126-3p are promising independent predictors of thrombotic events and can be used for ischemic risk stratification after AMI. |
format | Online Article Text |
id | pubmed-8230013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82300132021-06-26 MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty Hromadka, Milan Motovska, Zuzana Hlinomaz, Ota Kala, Petr Tousek, Frantisek Jarkovsky, Jiri Beranova, Marketa Jansky, Pavel Svoboda, Michal Krepelkova, Iveta Rokyta, Richard Widimsky, Petr Karpisek, Michal J Pers Med Article Aim. This study was designed to evaluate the relationship between microRNAs (miRNAs), miR-126-3p and miR-223-3p, as new biomarkers of platelet activation, and predicting recurrent thrombotic events after acute myocardial infarction (AMI). Methods and Results. The analysis included 598 patients randomized in the PRAGUE-18 study (ticagrelor vs. prasugrel in AMI). The measurements of miRNAs were performed by using a novel miRNA immunoassay method. The association of miRNAs with the occurrence of the ischemic endpoint (EP) (cardiovascular death, nonfatal MI, or stroke) and bleeding were analyzed. The miR-223-3p level was significantly related to an increased risk of occurrence of the ischemic EP within 30 days (odds ratio (OR) = 15.74, 95% confidence interval (CI): 2.07–119.93, p = 0.008) and one year (OR = 3.18, 95% CI: 1.40–7.19, p = 0.006), respectively. The miR-126-3p to miR-223-3p ratio was related to a decreased risk of occurrence of EP within 30 days (OR = 0.14, 95% CI: 0.03–0.61, p = 0.009) and one year (OR = 0.37, 95% CI: 0.17–0.82, p = 0.014), respectively. MiRNAs were identified as independent predictors of EP even after adjustment for confounding clinical predictors. Adding miR-223-3p and miR-126-3p to miR-223-3p ratios as predictors into the model calculating the ischemic risk significantly increased the predictive accuracy for combined ischemic EP within one year more than using only clinical ischemic risk parameters. No associations between miRNAs and bleeding complications were identified. Conclusion. The miR-223-3p and the miR-126-3p are promising independent predictors of thrombotic events and can be used for ischemic risk stratification after AMI. MDPI 2021-06-04 /pmc/articles/PMC8230013/ /pubmed/34199723 http://dx.doi.org/10.3390/jpm11060508 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hromadka, Milan Motovska, Zuzana Hlinomaz, Ota Kala, Petr Tousek, Frantisek Jarkovsky, Jiri Beranova, Marketa Jansky, Pavel Svoboda, Michal Krepelkova, Iveta Rokyta, Richard Widimsky, Petr Karpisek, Michal MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty |
title | MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty |
title_full | MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty |
title_fullStr | MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty |
title_full_unstemmed | MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty |
title_short | MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty |
title_sort | mir-126-3p and mir-223-3p as biomarkers for prediction of thrombotic risk in patients with acute myocardial infarction and primary angioplasty |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230013/ https://www.ncbi.nlm.nih.gov/pubmed/34199723 http://dx.doi.org/10.3390/jpm11060508 |
work_keys_str_mv | AT hromadkamilan mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty AT motovskazuzana mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty AT hlinomazota mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty AT kalapetr mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty AT tousekfrantisek mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty AT jarkovskyjiri mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty AT beranovamarketa mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty AT janskypavel mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty AT svobodamichal mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty AT krepelkovaiveta mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty AT rokytarichard mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty AT widimskypetr mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty AT karpisekmichal mir1263pandmir2233pasbiomarkersforpredictionofthromboticriskinpatientswithacutemyocardialinfarctionandprimaryangioplasty |